Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Amplia Therapuetics Limited

News headline image
Amplia Therapeutics Launches First Stage of Registration-Enabling Trial of Narmafotinib
From Amplia Therapuetics Limited
Via GlobeNewswire
Tickers ASX:ATX INNMF
News headline image
Amplia Therapeutics and Australia New Zealand Gynaecological Oncology Group (Anzgog) Announce Ovarian Cancer Study
From Amplia Therapuetics Limited
Via GlobeNewswire
Tickers ASX:ATX INNMF
News headline image
Accent Trial Mature Data Presented at International Conference
From Amplia Therapuetics Limited
Via GlobeNewswire
Tickers ASX:ATX INNMF
News headline image
Amplia Therapeutics Reports Four Additional Complete Responses and Improved Overall Survival Data in Accent Pancreatic Cancer Trial
From Amplia Therapuetics Limited
Via GlobeNewswire
Tickers ASX:ATX INNMF
News headline image
Poster Presentation Demonstrating Combination Benefit of Narmafotinib in Preclinical Kras-Mutated Cancer Models
From Amplia Therapuetics Limited
Via GlobeNewswire
Tickers ASX:ATX INNMF
News headline image
Amplia Therapeutics Announces Opening of US Sites for Amplicity Pancreatic Cancer Trial
From Amplia Therapuetics Limited
Via GlobeNewswire
Tickers ASX:ATX INNMF
News headline image
Amplia Therapeutics - Quarterly Activities and Cash Flow Reports - December 2025
From Amplia Therapuetics Limited
Via GlobeNewswire
Tickers ASX:ATX INNMF
News headline image
NARMAFOTINIB Large-Scale Manufactre Complete
From Amplia Therapuetics Limited
Via GlobeNewswire
Tickers ASX:ATX INNMF
News headline image
ACCENT DATA PRESENTED AT 2026 ASCO GASTROINTESTINAL CANCER SYMPOSIUM
From Amplia Therapuetics Limited
Via GlobeNewswire
Tickers ASX:ATX INNMF
News headline image
Amplia Therapeutics to Present at 2026 ASCO Gastrointestinal Cancers Symposium
From Amplia Therapuetics Limited
Via GlobeNewswire
Tickers ASX:ATX INNMF
News headline image
Amplia Enters into Second Agreement with Korean Specialist Drug Screening Company Next&Bio to Explore Combination Therapy with FAK Inhibitor and kRAS Inhibitors
From Amplia Therapuetics Limited
Via GlobeNewswire
Tickers ASX:ATX INNMF
News headline image
Additional Confirmed Response Reported as Part of Amplia Investor Presentation
From Amplia Therapuetics Limited
Via GlobeNewswire
Tickers ASX:ATX INNMF
News headline image
Key Narmafotinib Patent Granted in the U.S.
From Amplia Therapuetics Limited
Via GlobeNewswire
Tickers ASX:ATX INNMF
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.